|Ticker||Company name||Industry||Market Cap
|Dividend Yield||Dividend Frequency||Stock price||Currency||Stock Exchange|
|COLO-B||Coloplast AS||Healthcare||196.06||1.84 %||Semi-Annual||924.8||DKK||NASDAQ OMX Copenhagen|
Company's Past Performance
The 5 years average P/E ratio is the average of each year’s P/E ratios. P/E ratio in any year is limited to 30 in order to reduce the effect of the extreme values on the average P/E.
Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The Company supplies the products to hospitals, institutions as well as wholesalers and pharmacies. In selected markets, Coloplast A/S is a direct supplier to consumers (homecare). It has sales and customer service in more than 30 countries.